Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2001 3
2002 1
2003 2
2004 2
2005 5
2007 3
2008 3
2009 5
2010 3
2011 1
2013 4
2014 9
2015 7
2016 4
2017 5
2018 10
2019 3
2020 6
2021 15
2022 6
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Dizman N, et al. Among authors: kortylewski m. Nat Med. 2022 Apr;28(4):704-712. doi: 10.1038/s41591-022-01694-6. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228755 Free PMC article. Clinical Trial.
The revival of CpG oligonucleotide-based cancer immunotherapies.
Adamus T, Kortylewski M. Adamus T, et al. Among authors: kortylewski m. Contemp Oncol (Pozn). 2018 Mar;22(1A):56-60. doi: 10.5114/wo.2018.73887. Epub 2018 Mar 5. Contemp Oncol (Pozn). 2018. PMID: 29628795 Free PMC article. Review.
Revisiting TLR9 as a target for CLL therapy.
Kortylewski M. Kortylewski M. Blood. 2021 Jun 3;137(22):3006-3008. doi: 10.1182/blood.2020010618. Blood. 2021. PMID: 34081121 Free article. No abstract available.
Call for papers: Exploiting extracellular vesicles as therapeutic agents.
Frederickson RM, Ritter T, Morris K, Kortylewski M, Nasr M, Herzog RW. Frederickson RM, et al. Among authors: kortylewski m. Mol Ther. 2022 Mar 2;30(3):979. doi: 10.1016/j.ymthe.2022.02.007. Epub 2022 Feb 18. Mol Ther. 2022. PMID: 35182469 Free PMC article. No abstract available.
Noninvasive Delivery of Biologicals to the Brain.
Jordan S, Zielinski M, Kortylewski M, Kuhn T, Bystritsky A. Jordan S, et al. Among authors: kortylewski m. Focus (Am Psychiatr Publ). 2022 Jan;20(1):64-70. doi: 10.1176/appi.focus.20210028. Epub 2022 Jan 25. Focus (Am Psychiatr Publ). 2022. PMID: 35746928 Free PMC article.
Beclin-1 as a neutrophil-specific immune checkpoint.
Su YL, Kortylewski M. Su YL, et al. Among authors: kortylewski m. J Clin Invest. 2019 Dec 2;129(12):5079-5081. doi: 10.1172/JCI132534. J Clin Invest. 2019. PMID: 31657787 Free PMC article.
96 results